IT – INET Nordic “Scheduled Intraday Auction” in Test

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
IT – INET Nordic “Scheduled Intraday Auction” in Test - (81/13)

In INET OTF, the Scheduled Intraday Auction will run three times a day from Thursday October 10, 2013 at: 10:30 CET, 13:30 CET, and 15:30 CET.

From October 8, 2013, the Scheduled Intraday Auction has been configured in OTF with a full set-up and one daily Scheduled Intraday Auction.

To meet customer request to be able to test more efficiently, we have decided to run an additional two daily Scheduled Intraday Auctions on each of the five market segments on which the auction is implemented. This is for test purposes only and will start Thursday October 10, 2013. When launching in production December 2, 2013 there will be only the one planned scheduled intraday auction at 13:30 CET.

The five market segments comprising the Scheduled Intraday Auction are:

         
Market Segment Exchange Sequent Symbol New/Existing
OMX CPH Equities  XCSE 14 DKEQ SHR Existing
First North  XFND 100 FNDK CPH Existing
OMX HEL Equities intraday cross CCP   XHEL 201 FIEQ SHR IC New
First North Finland   FNFI 110 SEMM FN HEL Existing
OMX STO Equities intraday cross   XSTO 202 SEEQ SHR IC New

All three auctions will run for five minutes.

For more information on the Scheduled Intraday Auction please see IT Notices <65/13> dated August 28, 2013 and <76/13> dated October 4, 2014.

Support

If you have any questions regarding this Exchange Notice, please contact NASDAQ OMX Tech Support at: +46 8 405 6410, operator@nasdaqomx.com

 “NASDAQ OMX Nordic” is not a legal entity but describes the common offering from the NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, and Reykjavik.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

FDA Greenlights Kisqali®: A Major Step for Breast Cancer Care

Updated Category News Views 203

Kisqali® Receives FDA Approval for Early Breast Cancer Treatment Novartis has some exciting news for oncology: the US Food and Drug Administration (FDA) has officially approved Kisqali® (ribociclib) as a treatment for patients diagnosed with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early breast cancer...

Continue Reading
Ålandsbanken Abp Launches SEK 350M Additional Tier 1 Notes Series

Updated Category News Views 162

Ålandsbanken Abp Issues SEK 350,000,000 Additional Tier 1 Notes Ålandsbanken Abp, a prominent player in the banking industry, recently made waves in the financial market by issuing Additional Tier 1 floating rate notes amounting to SEK 350,000,000. The issuance marks a significant step in Ålandsbanken's strategic move to strengthen its capital position and enhance its...

Continue Reading
Harbour BioMed's 2025 Achievements and Future Prospects

Updated Category News Views 249

Harbour BioMed Achieves Significant Milestones in Interim Results Harbour BioMed (HKEX: 02142) is a prominent biopharmaceutical company focused on developing innovative antibody therapeutics, particularly in the fields of immunology and oncology. The company shared its impressive interim results for the first half of the year, showcasing remarkable growth and strategic...

Continue Reading
Innovative Investment Fuels Okika Devices' Future Growth Strategy

Updated Category News Views 187

Strategic Investment Boosts Okika Devices Advancement Colorado ONE Fund, which is part of the ONE Funds initiative, has made a major investment in Okika Devices, a company recognized for its innovation in Field Programmable Analog Array (FPAA) technology. This investment aligns with Colorado ONE Fund's mission to support technologies that advance the local innovation...

Continue Reading
Investors Take Note: Legal Options for Shareholders Explored

Updated Category News Views 61

Exploring Legal Options for Investors in Major Companies In recent developments, Halper Sadeh LLC, a reputable law firm focusing on investor rights, is carefully examining three significant companies for potential violations of federal securities laws. This investigation centers around the actions and decisions made by these firms, which may affect shareholders' rights...

Continue Reading